Anemia Increases Risk of End-Stage Kidney Disease in IgA Nephropathy
HCPLive
MAY 27, 2024
An analysis of more than 800 IgAN patients treated from 2002-2021 provides an overview of factors associated with anmeia as well as its impact on pgronosis.
HCPLive
MAY 27, 2024
An analysis of more than 800 IgAN patients treated from 2002-2021 provides an overview of factors associated with anmeia as well as its impact on pgronosis.
Cardiovascular Diabetology
OCTOBER 23, 2024
A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021) equation was shown to.
Cardiovascular Diabetology
AUGUST 6, 2024
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. vs. 10.5%) and chronic kidney disease (3.7% vs. 6.8%), myocardial infarction (7.7%
European Journal of Heart Failure
NOVEMBER 26, 2024
Methods and results Patients with HFrEF enrolled in the Swedish Heart Failure Registry between 2006 and 2021 were linked to the Prescribed Drug Register. Point prevalent use has been described, but the kinetics of discontinuation and the extent of reinitiation have not been studied.
Frontiers in Cardiovascular Medicine
DECEMBER 20, 2023
Background As a sensitive diagnostic marker for myocardial infarction (MI) in people with normal renal function, elevated high sensitivity cardiac troponin T (hs-cTnT) was often found in chronic kidney disease (CKD) patients requiring dialysis.
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Ferdinand, MD , ‘Boston Magazine’s 2021 Top Doctor’ Deepak L. The future of care demands a holistic approach.
Open Heart
APRIL 24, 2024
Results Data were collected in April 2012 to January 2014 and in June 2021 to December 2022. Frailty, chronic kidney disease and ischaemic heart disease increased significantly versus the first period (p<0.001). Statistical significance is determined at p<0.05. and 29.2%, p<0.001).
Let's personalize your content